CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023
Revenues:
Revenues	$ 57,800	$ 176,232
Operating expenses:
Research and development	111,521	234,057
General and administrative	44,727	61,167
Impairment of long-lived assets	5,521	65,528
Impairment of goodwill and indefinite-lived intangible assets	0	89,485
Total operating expenses	161,769	450,237
Loss from operations	(103,969)	(274,005)
Interest and other income, net	5,861	11,102
Loss before income taxes	(98,108)	(262,903)
Income tax benefit	(167)	(5,072)
Net loss	$ (97,941)	$ (257,831)
Basic net loss per share (in dollars per share)	$ (0.49)	$ (1.48)
Diluted net loss per share (in dollars per share)	$ (0.49)	$ (1.48)
Shares used in computing basic net loss per share (in shares)	201,699	174,444
Shares used in computing diluted net loss per share (in shares)	201,699	174,444

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.